Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Fiyaz Mohammed, Daniel H. Stones, Angela L. Zarling, Carrie R. Willcox, Jeffrey Shabanowitz, Kara L. Cummings, Donald F. Hunt, Mark Cobbold, Victor H. Engelhard, Benjamin E. Willcox
Published Apr 8, 2017 · Vol. 8, No. 33 · pp. 54160-54172
Changhoon Yoo, Jihoon Kang, Deokhoon Kim, Kyu-Pyo Kim, Baek-Yeol Ryoo, Seung-Mo Hong, Jung Jin Hwang, Seong-Yun Jeong, Shin Hwang, Ki-Hun Kim, Young-Joo Lee, Klaus P. Hoeflich, Oleg Schmidt-Kittler, Stephen Miller, Eun Kyung Choi
Published Apr 7, 2017 · Vol. 8, No. 24 · pp. 38592-38601
Lei Cai, Theodoros Michelakos, Cristina R. Ferrone, Liyuan Zhang, Vikram Deshpande, Qi Shen, Albert DeLeo, Teppei Yamada, Gong Zhang, Soldano Ferrone, Xinhui Wang
Published Apr 5, 2017 · Vol. 8, No. 23 · pp. 37646-37656